Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079989 | SCV000111880 | benign | not specified | 2012-09-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079989 | SCV000308760 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000079989 | SCV000519442 | benign | not specified | 2016-01-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001514414 | SCV001722254 | benign | Congenital muscular dystrophy due to integrin alpha-7 deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000079989 | SCV001880138 | benign | not specified | 2021-03-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000079989 | SCV000151477 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |